Gastrointestinal regulation of food intake: General aspects and focus on anandamide and oleoylethanolamide

被引:49
作者
Capasso, R.
Izzo, A. A.
机构
[1] Univ Naples Federico II, Dept Expt Pharmacol, I-80131 Naples, Italy
[2] Endocannabinoid Res Grp, Naples, Italy
关键词
anandamide; acylethanolamides; oleoylethanolamide; food intake; obesity;
D O I
10.1111/j.1365-2826.2008.01686.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The gastrointestinal tract plays a pivotal role in the regulation of food intake and energy balance. Signals from the gastrointestinal tract generally function to limit ingestion in the interest of efficient digestion. These signals may be released into the bloodstream or may activate afferent neurones that carry information to the brain and its cognitive centres, which regulates food intake. The rate at which nutrients become systemically available is also influenced by gastrointestinal motility: a delay in gastric emptying may evoke a satiety effect. Recent evidence suggests that the endocannabinoid anandamide and the related acylethanolamide oleoylethanolamide are produced in the intestine and might regulate feeding behaviour by engaging sensory afferent neurones that converge information to specific areas of the brain. The intestinal levels of these acylethanolamides are inversely correlated to feeding, as food deprivation increases intestinal levels of anandamide (which acts in the gut as a 'hunger signal'), while it decreases the levels of oleoylethanolamide (which acts in the gut as a 'satiety signal'). Additionally, these acylethanolamides, whose gastric levels change in response to diet-induced obesity, alter gastrointestinal motility, which might contribute to their effect on food intake and nutrient absorption.
引用
收藏
页码:39 / 46
页数:8
相关论文
共 52 条
[1]  
AVIELLO A, 2008, J MOL MED
[2]   Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases [J].
Bellocchio, Luigi ;
Mancini, Giacomo ;
Vicennati, Valentina ;
Pasquali, Renato ;
Pagotto, Uberto .
CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (06) :586-591
[3]   Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin [J].
Burdyga, G ;
Lal, S ;
Varro, A ;
Dimaline, R ;
Thompson, DG ;
Dockray, GJ .
JOURNAL OF NEUROSCIENCE, 2004, 24 (11) :2708-2715
[4]   Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance [J].
Burdyga, Galina ;
Varro, Andrea ;
Dimaline, Rod ;
Thompson, David G. ;
Dockray, Graham J. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 290 (06) :G1289-G1297
[5]   Appetite and obesity: a gastroenterologist's perspective [J].
Camilleri, M. ;
Grudell, A. B. M. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 (05) :333-341
[6]   Integrated upper gastrointestinal response to food intake [J].
Camilleri, Michael .
GASTROENTEROLOGY, 2006, 131 (02) :640-658
[7]   Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide [J].
Cani, PD ;
Montoya, ML ;
Neyrinck, AM ;
Delzenne, NM ;
Lambert, DM .
BRITISH JOURNAL OF NUTRITION, 2004, 92 (05) :757-761
[8]   Fatty acid amide hydrolase controls mouse intestinal motility in vivo [J].
Capasso, R ;
Matias, I ;
Lutz, B ;
Borrelli, F ;
Capasso, F ;
Marsicano, G ;
Mascolo, N ;
Petrosino, S ;
Monory, K ;
Valenti, M ;
Di Marzo, V ;
Izzo, AA .
GASTROENTEROLOGY, 2005, 129 (03) :941-951
[9]   Gastrointestinal hormones regulating appetite [J].
Chaudhri, Owais ;
Small, Caroline ;
Bloom, Steve .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2006, 361 (1471) :1187-1209
[10]   Cannabinoids, opioids and eating behavior:: The molecular face of hedonism? [J].
Cota, Daniela ;
Tschop, Matthias H. ;
Horvath, Tamas L. ;
Levine, Allen S. .
BRAIN RESEARCH REVIEWS, 2006, 51 (01) :85-107